Safety and efficacy of neoadjuvant immunochemotherapy in non-small-cell lung cancer: a comparative study of patients above and below 70 years

Background: The aging population presents significant challenges to healthcare worldwide. Evidence concerning the safety and efficacy of neoadjuvant immunochemotherapy in patients with non-small-cell lung cancer (NSCLC) aged 70 years or older remains limited. Objectives: To investigate the safety an...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Yuting Zheng, Mengting Huang, Qinyue Luo, Yimeng He, Hanting Li, Xiaoyu Han, Lijie Zhang, Heshui Shi
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	SAGE Publishing 2025-12-01
Schriftenreihe:	Therapeutic Advances in Medical Oncology
Online-Zugang:	https://doi.org/10.1177/17588359251399035
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!